Geron reported $2.97M in Interest Income for its fiscal quarter ending in June of 2026.





Interest Income Change Date
Bio Techne USD 1.37M 392K Jun/2026
Cassava Sciences USD 1.17M 47K Sep/2025
Cytokinetics USD 13.94M 2.92M Jun/2026
Exelixis USD 14.32M 105K Sep/2026
Genmab DKK 14M 11M Mar/2026
Geron USD 2.97M 450K Jun/2026
Gilead Sciences USD 45M 50M Jun/2026
Incyte USD 38.12M 4.43M Jun/2026
MacroGenics USD 1.37M 186K Jun/2026
Novavax USD 303K 27K Dec/2021